<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00782691</url>
  </required_header>
  <id_info>
    <org_study_id>2008/060</org_study_id>
    <nct_id>NCT00782691</nct_id>
  </id_info>
  <brief_title>Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.</brief_title>
  <official_title>Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <brief_summary>
    <textblock>
      Various methods of FDG-PET signal segmentation will be validated by correlation of
      histopathologically measured tumor dimensions in lymph node dissection specimens of
      head-and-neck cancer patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>How accurate are the various FDG-PET segmentation tools?</measure>
    <time_frame>Measurements are performed in conjunction with the clinical pathologist directly postoperatively.</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Head and Neck Cancer</condition>
  <arm_group>
    <arm_group_label>Head-and-neck cancer patients.</arm_group_label>
    <description>Head-and-neck cancer patients eligible for therapeutic lymph node dissection of cervical nodes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CT-FDG/PET scan of the head-and-neck region</intervention_name>
    <description>CT-FDG/PET scan of the head-and-neck region</description>
    <arm_group_label>Head-and-neck cancer patients.</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Head-and-neck cancer patients will undergo a therapeutic lymph node dissection of the
      cervical nodes. This treatment is given whether the patient is enrolled in the study or not.
      Histological specimens of cancer patients are always stored for possible future refference in
      the routine clinical practice.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Head-and-neck cancer patients eligible for therapeutic lymph node dissection of cervical
        nodes.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with N+ squamous cell carcinoma of the head and neck, planned for neck
             dissection.

          -  Age &gt;18 years.

        Exclusion Criteria:

          -  Pregnancy.

          -  Women breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dominic A.X. Schinagl, MD</last_name>
    <phone>NL24-3614515</phone>
    <email>d.schinagl@rther.umcn.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6500HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dominic AX Schinagl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2008</study_first_submitted>
  <study_first_submitted_qc>October 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2008</study_first_posted>
  <last_update_submitted>October 29, 2008</last_update_submitted>
  <last_update_submitted_qc>October 29, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2008</last_update_posted>
  <responsible_party>
    <name_title>D.A.X. Schinagl</name_title>
    <organization>Radboud University Nijmegen Medical Centre</organization>
  </responsible_party>
  <keyword>FDG-PET segmentation tools</keyword>
  <keyword>Head-and-neck cancer</keyword>
  <keyword>Histological validation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

